Level Chart

Basic Info

Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 351.80M, up from 339.50M last quarter and down from 986.90M one year ago. This is a change of 3.62% from last quarter and -64.35% from one year ago.

Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 351.80M
Latest Period Sep 2024
Last Updated Nov 29 2024, 08:30 EST
Next Release Feb 28 2025, 08:30 EST (E)
Average Growth Rate 9.13%
Value from Last Quarter 339.50M
Change from Last Quarter 3.62%
Value from 1 Year Ago 986.90M
Change from 1 Year Ago -64.35%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2024 351.80M
June 30, 2024 339.50M
March 31, 2024 834.00M
December 31, 2023 1.104B
September 30, 2023 986.90M
June 30, 2023 928.50M
March 31, 2023 777.80M
December 31, 2022 933.60M
September 30, 2022 866.40M
June 30, 2022 796.50M
Date Value
March 31, 2022 748.10M
December 31, 2021 956.60M
September 30, 2021 1.005B
June 30, 2021 785.50M
March 31, 2021 613.90M
December 31, 2020 700.70M
September 30, 2020 627.10M
June 30, 2020 548.30M
March 31, 2020 585.80M
December 31, 2019 409.50M

Basic Info

Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 351.80M, up from 339.50M last quarter and down from 986.90M one year ago. This is a change of 3.62% from last quarter and -64.35% from one year ago.

Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 351.80M
Latest Period Sep 2024
Last Updated Nov 29 2024, 08:30 EST
Next Release Feb 28 2025, 08:30 EST (E)
Average Growth Rate 9.13%
Value from Last Quarter 339.50M
Change from Last Quarter 3.62%
Value from 1 Year Ago 986.90M
Change from 1 Year Ago -64.35%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co 1.35%